FDA.reportPublic FDA data

METRONIDAZOLE

Substance profile for UNII 140QMO216E, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for METRONIDAZOLE
Structure render from PubChem CID 4173

Substance Identity#

UNII
140QMO216E
Preferred term
METRONIDAZOLE
Registry number
443-48-1
EC number
207-136-1
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C6H9N3O3
Chemical structure for METRONIDAZOLE
Structure render from PubChem CID 4173

Chemical And Database Identifiers#

InChIKey
VAOCPAMSLUNLGC-UHFFFAOYSA-N
SMILES
CC1=NC=C(N1CCO)[N+]([O-])=O
RxCUI
6922
PubChem
4173
NCIt
C651
INN ID
1032

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound4173https://pubchem.ncbi.nlm.nih.gov/compound/4173
PubChem InChIKey SearchVAOCPAMSLUNLGC-UHFFFAOYSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=VAOCPAMSLUNLGC-UHFFFAOYSA-N
RxNorm6922https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=6922
NCI ThesaurusC651https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C651
FDA Substance Registration System140QMO216Ehttps://precision.fda.gov/uniisearch/srs/unii/140QMO216E
European Community number207-136-1https://commonchemistry.cas.org/results?q=207-136-1

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
MetronidazoleACTIVE MOIETY140QMO216EMetronidazole Gel USP, 0.75%1
MetronidazoleACTIVE INGREDIENT140QMO216EMetronidazole Gel USP, 0.75%1
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLETS, USP 250 mg and 500 mg Revised: August 2014 Rx only3
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLETS, USP 250 mg and 500 mg Revised: August 2014 Rx only3
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLETS, USP 250 mg and 500 mg Revised: August 2014 Rx only1
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLETS, USP 250 mg and 500 mg Revised: August 2014 Rx only1
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLETS USP 500 mg Rx only6
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLETS USP 500 mg Rx only6
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLETS USP5
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLETS USP5
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLETS USP2
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLETS USP2
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMetronidazole Vaginal Gel, 0.75%1
METRONIDAZOLEACTIVE MOIETY140QMO216EMetronidazole Vaginal Gel, 0.75%1
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLETS USP 250 mg AND 500 mg Revised: April 2013 Rx only1
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLETS USP 250 mg AND 500 mg Revised: April 2013 Rx only1
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLETS USP1
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLETS USP1
METRONIDAZOLEACTIVE INGREDIENT140QMO216Efb79c214-e6ff-499a-9e23-a759bef9b7cb2
METRONIDAZOLEACTIVE MOIETY140QMO216Efb79c214-e6ff-499a-9e23-a759bef9b7cb2
METRONIDAZOLEACTIVE MOIETY140QMO216EROSACLEAR ® SYSTEM1
METRONIDAZOLEACTIVE INGREDIENT140QMO216EROSACLEAR ® SYSTEM1
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLETS USP2
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLETS USP2
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLETS USP1
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLETS USP1
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMetronidazole Vaginal Gel, 0.75%1
METRONIDAZOLEACTIVE MOIETY140QMO216EMetronidazole Vaginal Gel, 0.75%1
METRONIDAZOLEACTIVE INGREDIENT140QMO216EThese highlights do not include all the information needed to use METROGEL (metronidazole) Gel, 1% safely and effectively. See full prescribing information for METROGEL (metronidazole) Gel, 1% METROGEL® (metronidazole) Gel, 1% For topical use only. Initial U.S. Approval 19632
MetronidazoleACTIVE MOIETY140QMO216EThese highlights do not include all the information needed to use METROGEL (metronidazole) Gel, 1% safely and effectively. See full prescribing information for METROGEL (metronidazole) Gel, 1% METROGEL® (metronidazole) Gel, 1% For topical use only. Initial U.S. Approval 19632
METRONIDAZOLEACTIVE MOIETY140QMO216EMetronidazole Topical Gel USP, 0.75%1
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMetronidazole Topical Gel USP, 0.75%1
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLETS USP1
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLETS USP1
METRONIDAZOLEACTIVE MOIETY140QMO216E1787c491-d92c-4239-9d9f-6a91b629835d1
METRONIDAZOLEACTIVE INGREDIENT140QMO216E1787c491-d92c-4239-9d9f-6a91b629835d1
METRONIDAZOLEACTIVE INGREDIENT140QMO216Ebd3b62b6-4a80-495b-a1d3-d54eb15baf791
METRONIDAZOLEACTIVE MOIETY140QMO216Ebd3b62b6-4a80-495b-a1d3-d54eb15baf791
MetronidazoleACTIVE MOIETY140QMO216EThese highlights do not include all the information needed to use PYLERA safely and effectively. See full prescribing information for PYLERA. Initial U.S. Approval: 20061
MetronidazoleACTIVE INGREDIENT140QMO216EThese highlights do not include all the information needed to use PYLERA safely and effectively. See full prescribing information for PYLERA. Initial U.S. Approval: 20061
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLETS USP4
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLETS USP4
METRONIDAZOLEACTIVE INGREDIENT140QMO216E818dbe07-0267-4682-b171-5ab022ef98011
METRONIDAZOLEACTIVE MOIETY140QMO216E818dbe07-0267-4682-b171-5ab022ef98011
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLETS USP, 250 mg and 500 mg1
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLETS USP, 250 mg and 500 mg1
METRONIDAZOLEACTIVE MOIETY140QMO216EMetronidazole Injection2
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMetronidazole Injection2
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLETS, USP1
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLETS, USP1
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE Topical Cream 0.75%2
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE Topical Cream 0.75%2
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TOPICAL LOTION, 0.75%2
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TOPICAL LOTION, 0.75%2
metronidazoleACTIVE MOIETY140QMO216EMetronidazole Tablets USP Revised: July 2004 Rx only3
MetronidazoleACTIVE INGREDIENT140QMO216EMetronidazole Tablets USP Revised: July 2004 Rx only3
MetronidazoleACTIVE MOIETY140QMO216EMetronidazole Tablets USP Rx only1
MetronidazoleACTIVE INGREDIENT140QMO216EMetronidazole Tablets USP Rx only1
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3875
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3875
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLET [REMEDYREPACK INC. ]86
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLET [REMEDYREPACK INC. ]86
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLET [REMEDYREPACK INC. ]70
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLET [REMEDYREPACK INC. ]70
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLET [REMEDYREPACK INC. ]69
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLET [REMEDYREPACK INC. ]69
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLET [REMEDYREPACK INC. ]46
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLET [REMEDYREPACK INC. ]46
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE INJECTION, SOLUTION [HOSPIRA, INC.]14
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE INJECTION, SOLUTION [HOSPIRA, INC.]14
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE CAPSULE [HERITAGE PHARMACEUTICALS INC.]11
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE CAPSULE [HERITAGE PHARMACEUTICALS INC.]11
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE INJECTION, SOLUTION [CLARIS LIFESCIENCES INC.]11
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE INJECTION, SOLUTION [CLARIS LIFESCIENCES INC.]11
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLET [ACTAVIS PHARMA, INC.]11
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLET [ACTAVIS PHARMA, INC.]11
METRONIDAZOLEACTIVE MOIETY140QMO216EFLAGYL (METRONIDAZOLE) TABLET, FILM COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]10
METRONIDAZOLEACTIVE INGREDIENT140QMO216EFLAGYL (METRONIDAZOLE) TABLET, FILM COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]10
MetronidazoleACTIVE INGREDIENT140QMO216EPYLERA (BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, TETRACYCLINE HYDROCHLORIDE) CAPSULE [APTALIS PHARMA US, INC.]10
MetronidazoleACTIVE MOIETY140QMO216EPYLERA (BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE, TETRACYCLINE HYDROCHLORIDE) CAPSULE [APTALIS PHARMA US, INC.]10
METRONIDAZOLEACTIVE MOIETY140QMO216EFLAGYL (METRONIDAZOLE) CAPSULE [G.D. SEARLE LLC DIVISION OF PFIZER INC]9
METRONIDAZOLEACTIVE INGREDIENT140QMO216EFLAGYL (METRONIDAZOLE) CAPSULE [G.D. SEARLE LLC DIVISION OF PFIZER INC]9
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE SOLUTION [B. BRAUN MEDICAL INC.]9
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE SOLUTION [B. BRAUN MEDICAL INC.]9
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION]8
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE INJECTION, SOLUTION [BAXTER HEALTHCARE CORPORATION]8
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]7
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLET [NCS HEALTHCARE OF KY, INC DBA VANGARD LABS]7
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLET [PD-RX PHARMACEUTICALS, INC.]7
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLET [PD-RX PHARMACEUTICALS, INC.]7
MetronidazoleACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLET [REMEDYREPACK INC. ]7
MetronidazoleACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLET [REMEDYREPACK INC. ]7
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE (METRONIDAZOLE) TABLET [PD-RX PHARMACEUTICALS, INC.]6
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE (METRONIDAZOLE) TABLET [PD-RX PHARMACEUTICALS, INC.]6
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE GEL [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]6
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE GEL [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]6
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLET [CARDINAL HEALTH]6
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLET [CARDINAL HEALTH]6
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLET [PD-RX PHARMACEUTICALS, INC.]6
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLET [PD-RX PHARMACEUTICALS, INC.]6
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETROGEL (METRONIDAZOLE) GEL [GALDERMA LABORATORIES, L.P.]5
MetronidazoleACTIVE MOIETY140QMO216EMETROGEL (METRONIDAZOLE) GEL [GALDERMA LABORATORIES, L.P.]5
metronidazoleACTIVE INGREDIENT140QMO216EMETRONIDAZOLE CREAM [PRASCO LABORATORIES]5
metronidazoleACTIVE MOIETY140QMO216EMETRONIDAZOLE CREAM [PRASCO LABORATORIES]5
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE GEL [SANDOZ INC.]5
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE GEL [SANDOZ INC.]5
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE LOTION [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]5
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE LOTION [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]5
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLET [APPCO PHARMACEUTICALS CORP]5
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLET [APPCO PHARMACEUTICALS CORP]5
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLET [HERITAGE PHARMACEUTICALS INC.]5
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLET [HERITAGE PHARMACEUTICALS INC.]5
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE TABLET [PLIVA INC.]5
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE TABLET [PLIVA INC.]5
metronidazoleACTIVE INGREDIENT140QMO216ENORITATE (METRONIDAZOLE) CREAM [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]5
metronidazoleACTIVE MOIETY140QMO216ENORITATE (METRONIDAZOLE) CREAM [VALEANT PHARMACEUTICALS NORTH AMERICA LLC]5
metronidazoleACTIVE INGREDIENT140QMO216EMETRONIDAZOLE CREAM [E.FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]4
metronidazoleACTIVE MOIETY140QMO216EMETRONIDAZOLE CREAM [E.FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]4
METRONIDAZOLEACTIVE MOIETY140QMO216EMETRONIDAZOLE GEL [PRASCO LABORATORIES]4
METRONIDAZOLEACTIVE INGREDIENT140QMO216EMETRONIDAZOLE GEL [PRASCO LABORATORIES]4